dehydroepiandrosterone sulfate has been researched along with flutamide in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.90) | 18.7374 |
| 1990's | 14 (45.16) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 1 (3.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Kirschner, MA; Luthold, WW; Marcondes, JA; Minnani, SL; Samojlik, E; Wajchenberg, BL | 1 |
| Torday, JS | 1 |
| Belanger, A; Bergeron, V; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacoursiere, Y; Monfette, G | 1 |
| Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F | 1 |
| Ballerini, P; Fariselli, G; Recchione, C; Secreto, G; Zambetti, M | 1 |
| Bégin, D; Labrie, F; Luthy, IA | 1 |
| Armanini, D; Castello, R; Fontanarosa, MC; Magnani, CM; Moghetti, P; Muggeo, M; Negri, C; Tosi, F | 1 |
| Benz, R; Rossmanith, WG; Schenkel, B | 1 |
| Demirçay, Z; Durmuşoğlu, F; Erenus, M; Gürbüz, O; Pekin, S | 1 |
| Rabenbauer, B; Sir-Petermann, T; Wildt, L | 1 |
| Cusan, L; Dupont, A; Gomez, JL; Labrie, F; Tremblay, RR | 1 |
| Angelini, F; Barletta, D; Gargani, M; Genazzani, AD; Genazzani, AR; Lippi, F; Luisi, M; Monzani, F; Pucci, E | 1 |
| Chuzel, F; Clark, AM; Saez, JM; Sanchez, P | 1 |
| Bélanger, A; Flamand, M; Labrie, C; Labrie, F | 1 |
| De Fusco, D; Eleftheriou, G; Falsetti, L; Rosina, B | 1 |
| Diamanti-Kandarakis, E; Duleba, AJ; Mitrakou, A; Raptis, S; Tolis, G | 1 |
| Cariello, PL; D'Antona, D; De Leo, V; la Marca, A; Lanzetta, D; Morgante, G | 1 |
| Bayram, F; Müderris, II | 1 |
| Bayram, F; Güven, M; Müderris, II | 1 |
| Arora, TK; Burt, CM; Eagleson, CA; Evans, WS; Gingrich, MB; Marshall, JC; Pastor, CL | 1 |
| Barker, JL; Chang, YH; Li, Bs; Ma, W; Rubinow, DR; Zhang, L; Zhao, W | 1 |
| Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
| Carmina, E; Lobo, RA | 1 |
| Başogul, O; Inal, M; Ispahi, C; Karanfil, C; Onoglu, A; Taner, C; Tinar, S | 1 |
| Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
| Nakajima, A; Sekihara, H; Takahashi, H | 1 |
| Aral, Y; Culha, C; Demirbas, B; Karakurt, F; Kosar, F; Sahin, I; Serter, R; Taskapan, C | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Hutchison, SJ; Ko, E; Komesaroff, PA; Sudhir, K; Zellner, C | 1 |
| Chang, RJ; Malcom, PJ; Mehta, RV | 1 |
| Hara, N; Hoshii, T; Isahaya, E; Ishizaki, F; Nishiyama, T; Takahashi, K; Takizawa, I | 1 |
13 trial(s) available for dehydroepiandrosterone sulfate and flutamide
| Article | Year |
|---|---|
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival.
Topics: Acid Phosphatase; Anilides; Bone and Bones; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Testosterone | 1985 |
Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
Topics: Acne Vulgaris; Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Hirsutism; Humans; Leukocytes, Mononuclear; Receptors, Androgen; Testosterone | 1995 |
Role of androgens in the regulation of the human menstrual cycle.
Topics: Administration, Oral; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menstrual Cycle; Progesterone; Radioimmunoassay; Receptors, Androgen; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
Topics: Adolescent; Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone | 1994 |
Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
Topics: Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Premenopause; Progesterone; Spironolactone; Testosterone | 1994 |
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Finasteride; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1997 |
Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1999 |
A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Body Mass Index; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2000 |
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Topics: 17-alpha-Hydroxyprogesterone; Activity Cycles; Adult; Androgen Antagonists; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Reference Values; Thyroxine | 2000 |
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Arteries; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Placebos; Polycystic Ovary Syndrome; Pulse; Regional Blood Flow; Ultrasonography; Uterus | 2002 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Liver Function Tests; Prolactin; Severity of Illness Index; Testosterone; Treatment Outcome | 2002 |
Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Dehydroepiandrosterone Sulfate; Female; Flutamide; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2004 |
18 other study(ies) available for dehydroepiandrosterone sulfate and flutamide
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Treatment of hirsutism in women with flutamide.
Topics: Adult; Analysis of Variance; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 1992 |
Androgens delay human fetal lung maturation in vitro.
Topics: Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Fetal Organ Maturity; Flutamide; Humans; Lung; Phosphatidylcholines; Pulmonary Surfactants | 1990 |
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate.
Topics: Aged; Aminoglutethimide; Androstane-3,17-diol; Androstanols; Androsterone; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flutamide; Glucuronates; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1987 |
Hormonal changes induced by the pure antiandrogen flutamide in postmenopausal women with advanced breast cancer.
Topics: Anilides; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Flutamide; Gonadal Steroid Hormones; Hormones; Humans; Middle Aged; Time Factors | 1988 |
Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro.
Topics: Androgens; Androstenediol; Androstenediols; Androstenedione; Animals; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flutamide; Growth; Male; Mammary Neoplasms, Experimental; Mice; Tumor Cells, Cultured | 1988 |
The effect of flutamide on pulsatile gonadotrophin secretion in hyperandrogenaemic women.
Topics: Adolescent; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Luteinizing Hormone; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Ultrasonography | 1995 |
Regulation by gonadotropins of the messenger ribonucleic acid for P450 side-chain cleavage, P450(17) alpha-hydroxylase/C17,20-lyase, and 3 beta-hydroxysteroid dehydrogenase in cultured pig Leydig cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Aminoglutethimide; Animals; Aromatase Inhibitors; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Chorionic Gonadotropin; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Flutamide; Gene Expression Regulation, Enzymologic; Gonadotropins; Kinetics; Leydig Cells; Luteinizing Hormone; Male; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Swine; Testosterone | 1996 |
High bioavailability of dehydroepiandrosterone administered percutaneously in the rat.
Topics: Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Animals; Biological Availability; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Luteinizing Hormone; Male; Organ Size; Ovariectomy; Prostate; Rats; Rats, Sprague-Dawley; Uterus | 1996 |
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1998 |
Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Androgen Antagonists; Androgens; Androstenedione; Area Under Curve; Corticotropin-Releasing Hormone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hydrocortisone; Pituitary-Adrenal System; Polycystic Ovary Syndrome; Testosterone | 1998 |
Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways.
Topics: Androgen Antagonists; Animals; Apoptosis; Chromones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fetal Proteins; Flutamide; Morpholines; Nerve Tissue Proteins; Neurons; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Telencephalon | 2002 |
Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgen Antagonists; Androgens; Androstenedione; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipids; Obesity; Polycystic Ovary Syndrome; Steroids; Testosterone | 2004 |
Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
Topics: Adult; Apoptosis; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flow Cytometry; Flutamide; Humans; Lymphocytes; Male; Middle Aged; Staurosporine; Tamoxifen | 2004 |
Dehydroepiandrosterone sulfate induces acute vasodilation of porcine coronary arteries in vitro and in vivo.
Topics: Androgen Antagonists; Animals; ATP-Binding Cassette Transporters; Coronary Circulation; Coronary Vessels; Dehydroepiandrosterone Sulfate; Echocardiography, Doppler; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Female; Flutamide; Fulvestrant; Glyburide; Hemodynamics; In Vitro Techniques; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Pericardium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Sex Characteristics; Swine; Testosterone; Vasodilation | 2005 |
The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androstenedione; Area Under Curve; Cohort Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Flutamide; Follicle Stimulating Hormone; Granulosa Cells; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone; Prospective Studies; Recombinant Proteins; Sex Hormone-Binding Globulin; Testosterone | 2006 |
Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
Topics: Adrenocorticotropic Hormone; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone Sulfate; Flutamide; Goserelin; Human Growth Hormone; Humans; Immunoassay; Insulin-Like Growth Factor I; Logistic Models; Luteinizing Hormone; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 2012 |